Pharmacokinetics of FCE 22891, a new oral penem.

FCE 22891 is the oral prodrug of FCE 22101, a new broad-spectrum penem. The pharmacokinetics of FCE 22891 after single-dose administration, its absolute bioavailability, and the effect of food intake on its absorption were investigated in three different randomized crossover studies in healthy volun...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Saathoff, A, Lode, H, Hampel, B, Deppermann, K M, Borner, K, Koeppe, P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171746/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2203300/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.6.1001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!